NASDAQ
Boundless Bio, Inc. (BOLD) has a free cash flow growth of -42.25% as of Friday, May 29, 2026. This represents a 539.33% decrease compared to its 12-month average of 9.62%. Free cash flow growth tracks the year-over-year percentage change in cash generated after capital expenditures.
No price data available for this timeframe.